SEC Form 4 · accession 0001144204-15-054904
Cytosorbents Corp · CTSO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Al Kraus
Director
Period of report
Sep 10, 2015
Accepted (ET)
Sep 14, 2015 · 5:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175151
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 10, 2015 | M | 10,000 | $0.875 | A | 65,746 | D | |
| Common Stock | Sep 10, 2015 | S | 10,000 | $7.26 | D | 55,746 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | $0.875 | Sep 10, 2015 | M | 10,000 | D | Jun 25, 2008 | Jun 25, 2018 | Common Stock | 10,000 | 56,773 | D |
Explanation of responses
- F1Stock option exercise and open market sales pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with rule 10b5-1 of the Securities Exchange Act of 1934, as amended.